Paper33333012
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.
Koehler P and 35 others. Lancet Infect Dis, 2021. Cited by 750 papers, by iCite.
Cite this record
ConductScience Library. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance. Papers, record 33333012. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33333012
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antifungal Agents | Major topic |
| COVID-19 | Major topic |
| Coinfection | Major topic |
| Pulmonary Aspergillosis | Major topic |
| Amphotericin B | |
| Azoles | |
| Humans | |
| Nitriles | |
| Pyridines | |
| SARS-CoV-2 | |
| Triazoles | |
| Voriconazole |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT05860387 | Early Diagnosis of Invasive Lung Aspergillosis | Background |
Source ClinicalTrials.gov
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 33662323 | Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis - Authors' reply. | https://conductscience.org/library/papers/33662323 | PubMed |
| Comment in | 33662327 | Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis. | https://conductscience.org/library/papers/33662327 | PubMed |
References82
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12167683 | Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. | N Engl J Med | 2002 | https://conductscience.org/library/papers/12167683 | PubMed |
| 2 | 27365388 | Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. | Clin Infect Dis | 2016 | https://conductscience.org/library/papers/27365388 | PubMed |
| 3 | 25599346 | Combination antifungal therapy for invasive aspergillosis: a randomized trial. | Ann Intern Med | 2015 | https://conductscience.org/library/papers/25599346 | PubMed |
| 4 | 31649174 | New drugs target growing threat of fatal fungi. | Science | 2019 | https://conductscience.org/library/papers/31649174 | PubMed |
| 5 | 26603290 | Important drug classes associated with potential drug-drug interactions in critically ill patients: highlights for cardiothoracic intensivists. | Ann Intensive Care | 2015 | https://conductscience.org/library/papers/26603290 | PubMed |
| 6 | 25947367 | Impact of special patient populations on the pharmacokinetics of echinocandins. | Expert Rev Anti Infect Ther | 2015 | https://conductscience.org/library/papers/25947367 | PubMed |
| 7 | 32918497 | Bronchoscopy safety precautions for diagnosing COVID-19 associated pulmonary aspergillosis-A simulation study. | Mycoses | 2021 | https://conductscience.org/library/papers/32918497 | PubMed |
| 8 | 22152763 | Pandemic 2009 influenza A(H1N1) virus infection coinciding with invasive pulmonary aspergillosis in neutropenic patients. | Epidemiol Infect | 2012 | https://conductscience.org/library/papers/22152763 | PubMed |
| 9 | 32599813 | COVID-19 Associated Pulmonary Aspergillosis (CAPA)-From Immunology to Treatment. | J Fungi (Basel) | 2020 | https://conductscience.org/library/papers/32599813 | PubMed |
| 10 | 32402155 | Multiorgan and Renal Tropism of SARS-CoV-2. | N Engl J Med | 2020 | https://conductscience.org/library/papers/32402155 | PubMed |
| 11 | 22517788 | A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients. | Am J Respir Crit Care Med | 2012 | https://conductscience.org/library/papers/22517788 | PubMed |
| 12 | 32585069 | COVID-19-associated pulmonary aspergillosis (CAPA) in patients admitted with severe COVID-19 pneumonia: An observational study from Pakistan. | Mycoses | 2020 | https://conductscience.org/library/papers/32585069 | PubMed |
| 13 | 32678530 | Dexamethasone in Hospitalized Patients with Covid-19. | N Engl J Med | 2021 | https://conductscience.org/library/papers/32678530 | PubMed |
| 14 | 2543220 | Treatment of invasive aspergillosis with itraconazole. | Am J Med | 1989 | https://conductscience.org/library/papers/2543220 | PubMed |
| 15 | 32445626 | Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19. | Lancet Respir Med | 2020 | https://conductscience.org/library/papers/32445626 | PubMed |
| 16 | 32664423 | Is the COVID-19 Pandemic a Good Time to Include Aspergillus Molecular Detection to Categorize Aspergillosis in ICU Patients? A Monocentric Experience. | J Fungi (Basel) | 2020 | https://conductscience.org/library/papers/32664423 | PubMed |
| 17 | 23629724 | Potential factors for inadequate voriconazole plasma concentrations in intensive care unit patients and patients with hematological malignancies. | Antimicrob Agents Chemother | 2013 | https://conductscience.org/library/papers/23629724 | PubMed |
| 18 | 32488446 | COVID-19-associated invasive pulmonary aspergillosis. | Ann Intensive Care | 2020 | https://conductscience.org/library/papers/32488446 | PubMed |
| 19 | 32835328 | Diagnosing COVID-19-associated pulmonary aspergillosis. | Lancet Microbe | 2020 | https://conductscience.org/library/papers/32835328 | PubMed |
| 20 | 32284951 | Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options. | Open Forum Infect Dis | 2020 | https://conductscience.org/library/papers/32284951 | PubMed |
Cited by568
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 750 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42930735 | Invasive Fungal Disease in High-Acuity Hospitals in Latin America: Practical Pathways from Suspicion to Early Targeted Therapy. | J Fungi (Basel) | 2026 | https://conductscience.org/library/papers/42930735 | PubMed |
| 42930727 | Immune Profile and Risk of COVID-19-Associated Pulmonary Aspergillosis (CAPA): A Multicenter Retrospective Study with Matching Cohorts. | J Fungi (Basel) | 2026 | https://conductscience.org/library/papers/42930727 | PubMed |
| 42851473 | Disseminated Aspergillus flavus infection presenting as spondylodiscitis: a fatal tuberculosis mimicker in an immunocompetent host - case report and literature review. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42851473 | PubMed |
| 42840056 | Detection of Aspergillus in the lower respiratory tract and its association with mortality in patients with different viral pneumonias: a retrospective multicenter cohort study from China. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42840056 | PubMed |
| 42795534 | Increase in Healthcare-Associated Infections: Is COVID-19 Responsible? A Narrative Review. | Microorganisms | 2026 | https://conductscience.org/library/papers/42795534 | PubMed |
| 42783978 | Epidemiological Characteristics of Clinical Aspergillus Section Nigri and Mutations in cyp51A Gene. | J Fungi (Basel) | 2026 | https://conductscience.org/library/papers/42783978 | PubMed |
| 42783947 | Invasive Aspergillosis Complicating Severe COVID-19: Cumulative Incidence, Risk Factors, and Outcomes Between the First Wave of the Pandemic and Subsequent Waves, According to the ECMM/ISHAM Classification and a Local Case Assessment. | J Fungi (Basel) | 2026 | https://conductscience.org/library/papers/42783947 | PubMed |
| 42682890 | Unclassifiable Invasive Pulmonary Aspergillosis in the Intensive Care Unit: Insights From a Multicenter, Retrospective Cohort Study in France (2022-2024). | Open Forum Infect Dis | 2026 | https://conductscience.org/library/papers/42682890 | PubMed |
| 42646096 | Evaluation of Molecular Assays for Rapid Diagnosis of Invasive Fungal Infections: Clinical Experience with the Commercial CandID and AspID Real-Time PCR Assays in Paraguay. | J Fungi (Basel) | 2026 | https://conductscience.org/library/papers/42646096 | PubMed |
| 42604214 | Dose-response relationship of pre-ICU corticosteroids and influenza-associated pulmonary aspergillosis: a multicenter target trial emulation. | Ann Intensive Care | 2026 | https://conductscience.org/library/papers/42604214 | PubMed |
| 42604071 | Invasive pulmonary aspergillosis following mild Covid-19 in an autologous hematopoietic stem cell transplant recipient: A case report. | Med Mycol Case Rep | 2026 | https://conductscience.org/library/papers/42604071 | PubMed |
| 42559192 | Interpreting combined BALF-galactomannan and next-generation sequencing in pulmonary aspergillosis and mucormycosis: a two-center clinical decision framework. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42559192 | PubMed |
| 42547600 | 30 years in service, 1996-2026: Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). | Ann Hematol | 2026 | https://conductscience.org/library/papers/42547600 | PubMed |
| 42506302 | Oxygenation-Based Severity Stratification and a Proposed Clinical Diagnostic Workflow for Non-HIV Pneumocystis jirovecii Pneumonia: A Single-Center Observational Study. | J Fungi (Basel) | 2026 | https://conductscience.org/library/papers/42506302 | PubMed |
| 42506260 | Diagnostic Failure in Invasive Fungal Infections: Causes, Clinical Consequences, and Mitigation Strategies. | J Fungi (Basel) | 2026 | https://conductscience.org/library/papers/42506260 | PubMed |
| 42506220 | Non-Interventional, Retrospective, Multicenter Study on the Renal Safety of Liposomal Amphotericin B in Critically Ill Patients with Invasive Pulmonary Aspergillosis. | J Fungi (Basel) | 2026 | https://conductscience.org/library/papers/42506220 | PubMed |
| 42489754 | Real-world study of effectiveness and safety compared among isavuconazole, amphotericin B, and voriconazole in invasive mold disease patients. | Eur J Clin Microbiol Infect Dis | 2026 | https://conductscience.org/library/papers/42489754 | PubMed |
| 42455266 | Pathogen patterns in viral ARDS on V-V ECMO: a single-center experience. | Infection | 2026 | https://conductscience.org/library/papers/42455266 | PubMed |
| 42432685 | Incidence, mortality and risk factors of invasive pulmonary aspergillosis in critically ill patients during the COVID-19 era: a global systematic review and meta-analysis. | Ann Clin Microbiol Antimicrob | 2026 | https://conductscience.org/library/papers/42432685 | PubMed |
| 42384022 | The clinical utility of bronchoalveolar lavage galactomannan result stewardship within a tertiary medical system. | Med Mycol | 2026 | https://conductscience.org/library/papers/42384022 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BCL2 | 596 | PubTator's text mining | https://conductscience.org/library/genes/596 | NCBI Gene |
| CYP2C19 | 1557 | PubTator's text mining | https://conductscience.org/library/genes/1557 | NCBI Gene |
| CYP2C9 | 1559 | PubTator's text mining | https://conductscience.org/library/genes/1559 | NCBI Gene |
| CYP3A4 | 1576 | PubTator's text mining | https://conductscience.org/library/genes/1576 | NCBI Gene |
| IL6 | 3569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33333012
GET https://conductscience.org/api/papers/v1/33333012/authors?page=2